Led · Equity · May 2019

BHE provides a SaaS Instant Health Data (IHD) platform, a real-world evidence (RWE) analytics solution used by over two dozen major life science and research organizations. The IHD platform supports rapid analysis of more than 20 disparate real-world data sets, including claims, laboratory results, electronic medical records, hospital and integrated data sources. The company is led by Founder and CEO Joseph Menzin, Ph.D., with Jordan Menzin as Chief Technology Officer. BHE intends to use new funding to accelerate development and market expansion of its platform. Financially, the company secured a significant minority growth investment to support that growth plan.

Led · Equity · Nov 2018

PatientPop offers a complete practice growth solution that enhances and automates each touchpoint in the patient journey, from online discovery to digital booking and post-appointment follow-up. Led by Co-CEOs Luke Kervin and Travis Schneider, the platform helps providers attract more patients, manage online reputation, modernize the patient experience, and automate front-office operations. The company plans to use new funding to continue product development and to expand operations and business reach. The product focus is on improving provider visibility and streamlining patient interactions across digital channels. The article does not disclose operating metrics such as revenue or user counts. PatientPop is a Santa Monica, California-based company that offers a cloud-based, HIPAA-compliant practice growth platform for healthcare providers. Its product helps providers attract new patients, manage online reputation, modernize the patient experience, streamline front-office operations, enable online scheduling and send appointment reminders, and integrates with EMRs. The company serves practices across multiple specialties and lists clients including Speck Health, Allegra Dental, Got Your Back Total Health, and Aventura OB/GYN. PatientPop plans to use the $25 million raise to expand go-to-market capabilities and further innovate its platform. The company has raised $75 million to date and reports a headcount of more than 330 employees and additional offices. Co-founder and co-CEO Luke Kervin highlighted the company's growth and technology evolution since 2015. PatientPop offers a practice growth platform that helps healthcare providers manage patient acquisition, retention, reputation and analytics through a single interface synced with their electronic medical records and practice management system. The company was launched in October 2014 by Co-CEOs Luke Kervin and Travis Schneider. At the time of the article it had more than 65 employees and offices in Santa Monica, Las Vegas and New York. PatientPop raised a $10M Series A from Toba Capital, bringing total funding to $13.3M. The company intends to use the funds to scale to more than 200 employees the following year and to expand its presence across the United States. No revenue or user metrics were disclosed in the article.

Participated · Equity · Apr 2018

Vera Whole Health offers high-touch, whole-person primary care delivered by teams of primary care physicians, nurses, and health coaches supported by clinics and an integrated technology platform. The company operates a network of advanced primary care centers in Arizona, Washington, California, Oregon, Idaho, Alaska, Texas, Missouri, Kansas and Nevada and has a partnership with Central Ohio Primary Care. Vera’s model emphasizes care coordination and value-based payment, aiming to shift employer-sponsored care away from fee-for-service toward globally capitated arrangements. Employers under contract with Vera have seen an average patient Net Promoter Score of 90 and reported improved health outcomes and utilization. Vera recently completed a majority-stake sale to Clayton, Dubilier & Rice and is now receiving strategic investment to scale its coordinated care model. The company is positioning to expand employer-facing value-based programs and to align financial incentives to support care coordination and better outcomes. Vera Whole Health runs on‑site, employer‑sponsored primary care clinics located inside corporate workplaces and charges a monthly per‑person membership fee often covered or subsidized by employers. Its care model emphasizes longer visits, health coaching, and a fee‑for‑value approach that refunds money if outcomes aren’t achieved. The company says its clinics can meet 90% of a patient’s needs and report low outside referral rates. Vera currently operates 11 clinics across five states and counts clients such as the Bill and Melinda Gates Foundation, Virginia Mason and Seattle Children’s. The company plans to open six additional clinics by the end of the year. Vera employs 170 people, including about 70 staff at its Seattle headquarters. Vera Whole Health delivers employer-funded onsite primary, preventive, urgent and worker’s comp care to employer clients. Its services are aimed at helping employers — from hospitals and educational institutions to government entities and industrial companies — reduce costs and improve employee health and well-being. The company operates in multiple western states and plans to expand into five new markets this year. Led by president and CEO Ryan Schmid, Vera focuses on enhancing the capabilities of its worksite health solution. The company recently completed a $24M Series D round to support national expansion and continued product capability development. The business model centers on providing on-site primary care funded by employers.

Participated · Equity · May 2017

Outcome Health (formerly ContextMedia) builds digital patient-engagement products delivered via waiting-room screens, a physician app, interactive exam-room tablets and a large interactive digital exam wall board that can present 3-D views. Its platform integrates decision-support tools such as WiserCare to help patients weigh treatment options. The company employs about 600 people across offices in Chicago and New York and, after acquiring Accent Health in November 2016, expanded its footprint from roughly 30,000 to 55,000 physician practices. Outcome Health has set a goal to increase penetration from 20% to 70% of physician practices by 2020 and plans to use new funding to add provider customers, invest in product and engineering, extend its suite and expand into additional markets. It is also pursuing growth opportunities in clinical trials as a new area of expansion. Financially, the company has closed its first financing — a $500 million growth equity round that values the business at about $5 billion.

Led · Equity · May 2017

Scientist.com operates the world's largest marketplace for outsourced research and scientific services, connecting buyers and sellers of pharmaceutical research services and showcasing innovative tools and technologies. The platform streamlines the source-to-settle process and hosts thousands of commercial suppliers (CROs). Scientist.com currently operates private marketplaces for 12 of the top 25 large pharmaceutical companies and the US National Institutes of Health. The company enables both large and early-stage biopharmaceutical firms to outsource most laboratory tests and studies via a private marketplace at app.scientist.com. It raised $24M in equity financing to expand its marketplace, grow its team of industry experts, and bring additional simplification and innovation to drug research. The announcement originated from San Diego and the company formerly operated as Assay Depot. Assay Depot operates an online marketplace that lets scientists source and purchase research services across more than 500 research areas. The company runs public and private marketplaces; private marketplaces serve as end-to-end vendor relationship management (VRM) systems that link scientists inside large pharmaceutical companies with 9,000 global research suppliers. Its platform is used by scientists in over 100 countries and provides ratings and reviews to capture scientist feedback. Assay Depot positions itself as the world's largest marketplace for scientific services and enables ordering services on demand, allowing research projects to be carried out without direct access to a laboratory. The company raised $3 million in Series B financing led by Bootstrap Venture Fund and will use the funds to drive continued growth of its research sourcing platform. Assay Depot operates a cloud-based pharmaceutical research platform and online marketplace that lets scientists custom-create and purchase research services and communicate with experts. The platform includes a public marketplace launched in 2008 that hosts services needed to run a drug program from initial concept to human clinical trials. It also offers private marketplaces called Contract Research Exchanges (CRXs) for companies to manage their worldwide network of internal and external research providers, and a vendor back office where vendors respond to requests and manage orders. The company raised $1.7M from private investors to expand the platform. Assay Depot is led by President and CEO Kevin Lustig and is based in San Diego, California. The company also maintains offices in Northern California and Pennsylvania.